Anti-NIPA2/ SLC57A2 monoclonal antibody

Anti-NIPA2/ SLC57A2 antibody for FACS & in-vivo assay

Target products collectionGo to NIPA2/NIPA2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0879-Ab-1/ GM-Tg-hg-MP0879-Ab-2Anti-Human NIPA2 monoclonal antibodyHuman
GM-Tg-rg-MP0879-Ab-1/ GM-Tg-rg-MP0879-Ab-2Anti-Rat NIPA2 monoclonal antibodyRat
GM-Tg-mg-MP0879-Ab-1/ GM-Tg-mg-MP0879-Ab-2Anti-Mouse NIPA2 monoclonal antibodyMouse
GM-Tg-cynog-MP0879-Ab-1/ GM-Tg-cynog-MP0879-Ab-2Anti-Cynomolgus/ Rhesus macaque NIPA2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0879-Ab-1/ GM-Tg-felg-MP0879-Ab-2Anti-Feline NIPA2 monoclonal antibodyFeline
GM-Tg-cang-MP0879-Ab-1/ GM-Tg-cang-MP0879-Ab-2Anti-Canine NIPA2 monoclonal antibodyCanine
GM-Tg-bovg-MP0879-Ab-1/ GM-Tg-bovg-MP0879-Ab-2Anti-Bovine NIPA2 monoclonal antibodyBovine
GM-Tg-equg-MP0879-Ab-1/ GM-Tg-equg-MP0879-Ab-2Anti-Equine NIPA2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0879-Ab-1/ GM-Tg-hg-MP0879-Ab-2; GM-Tg-rg-MP0879-Ab-1/ GM-Tg-rg-MP0879-Ab-2;
GM-Tg-mg-MP0879-Ab-1/ GM-Tg-mg-MP0879-Ab-2; GM-Tg-cynog-MP0879-Ab-1/ GM-Tg-cynog-MP0879-Ab-2;
GM-Tg-felg-MP0879-Ab-1/ GM-Tg-felg-MP0879-Ab-2; GM-Tg-cang-MP0879-Ab-1/ GM-Tg-cang-MP0879-Ab-2;
GM-Tg-bovg-MP0879-Ab-1/ GM-Tg-bovg-MP0879-Ab-2; GM-Tg-equg-MP0879-Ab-1/ GM-Tg-equg-MP0879-Ab-2
Products NameAnti-NIPA2 monoclonal antibody
Formatmab
Target NameNIPA2
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-NIPA2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species NIPA2/ SLC57A2 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMLP003991human NIPA2 Lentivirus particle
    ORF Viral VectorpGMLP003991human NIPA2 Lentivirus plasmid
    ORF Viral VectorpGMLPm002496mouse Nipa2 Lentivirus plasmid
    ORF Viral VectorvGMLPm002496mouse Nipa2 Lentivirus particle


    Target information

    Target IDGM-MP0879
    Target NameNIPA2
    Gene ID81614,93790,308667,710147,479002,101089997,507430,100051099
    Gene Symbol and Synonyms2600017P10Rik,3830408P04Rik,NIPA2,RGD1306051,SLC56A2,SLC57A2
    Uniprot AccessionQ8N8Q9,Q3SWX0
    Uniprot Entry NameNIPA2_HUMAN,NIPA2_BOVIN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000140157
    Target ClassificationN/A

    The target: NIPA2, gene name: NIPA2, also named as SLC57A2. This gene encodes a possible magnesium transporter. This gene is located adjacent to the imprinted domain in the Prader-Willi syndrome deletion region of chromosome 15. Alternate splicing results in multiple transcript variants. Pseudogenes of this gene are found on chromosomes 3, 7 and 21.[provided by RefSeq, May 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.